Kumar Manoj, Kainth Sumeet, Kumar Sachin, Bhardwaj Ankit, KumarAggarwal Hemant, Maiwall Rakhi, Jamwal Kapil D, Shasthry Saggere M, Jindal Ankur, Choudhary Ashok, Anand Lovkesh, Dhamija Ravinder M, Chibbar Guresh, Chander Sharma Barjesh, Sarin Shiv K
Department of Hepatology and Liver Transplantation, New Delhi, India.
Department of Pulmonary Medicine, New Delhi, India.
J Clin Exp Hepatol. 2021 Jul-Aug;11(4):453-465. doi: 10.1016/j.jceh.2020.10.006. Epub 2020 Oct 24.
BACKGROUND & AIMS: Sleep-wake abnormalities [poor nighttime sleep and excessive daytime sleepiness (EDS)] are common in patients with cirrhosis. The aim of this study was to assess the prevalence of sleep-wake abnormalities and clinical factors associated with these abnormalities in a group of patients with cirrhosis.
1098 patients with cirrhosis [Child Turcotte Pugh (CTP) class A, 22.2%; CTP class B, 29.2% and CTP class C, 48.6%], with either no ascites or mild ascites controlled on diuretics, and no history of or current overt hepatic encephalopathy were included in the study.
Poor nighttime sleep and EDS were found in 569 (51.8%) and 489 (44.5%) patients respectively. On multivariate analysis, factors associated with poor nighttime sleep were CTP class C (vs. class A), presence of minimal hepatic encephalopathy (MHE), intermediate or evening type of diurnal preference category (vs. morning type), high risk for obstructive sleep apnea (OSA), diuretic use, presence of major depression, and presence of generalized anxiety disorder (GAD). Factors associated with EDS on multivariate analysis were CTP class B and C (vs. class A), intermediate or evening type of diurnal preference category (vs. morning type), high risk for OSA, presence of major depression, and presence of GAD.
Sleep-wake abnormalities are common in patients with cirrhosis. CTP status, diurnal preference chronotype, risk of OSA, major depression and GAD are associated with both poor nighttime sleep and EDS. MHE and diuretic use are associated with poor nighttime sleep, but not with EDS.
睡眠-觉醒异常(夜间睡眠差和日间过度嗜睡[EDS])在肝硬化患者中很常见。本研究旨在评估一组肝硬化患者中睡眠-觉醒异常的患病率以及与这些异常相关的临床因素。
本研究纳入了1098例肝硬化患者[Child Turcotte Pugh(CTP)分级:A级占22.2%;B级占29.2%;C级占48.6%],这些患者无腹水或使用利尿剂可控制的轻度腹水,且无既往或当前显性肝性脑病病史。
分别有569例(51.8%)患者存在夜间睡眠差,489例(44.5%)患者存在日间过度嗜睡。多因素分析显示,与夜间睡眠差相关的因素有CTP C级(与A级相比)、轻微肝性脑病(MHE)的存在、昼夜偏好类别为中间型或夜间型(与早晨型相比)、阻塞性睡眠呼吸暂停(OSA)高风险、使用利尿剂、存在重度抑郁症以及存在广泛性焦虑障碍(GAD)。多因素分析显示,与日间过度嗜睡相关的因素有CTP B级和C级(与A级相比)、昼夜偏好类别为中间型或夜间型(与早晨型相比)、OSA高风险、存在重度抑郁症以及存在GAD。
睡眠-觉醒异常在肝硬化患者中很常见。CTP分级状态、昼夜偏好时型、OSA风险、重度抑郁症和GAD与夜间睡眠差和日间过度嗜睡均相关。MHE和利尿剂的使用与夜间睡眠差相关,但与日间过度嗜睡无关。